Company Profile
Johnson Matthey Pharmaceutical Materials, based in West Deptford, New Jersey, USA, is a leading manufacturer of active pharmaceutical ingredients.
VIEW MORE VIEW LESSProduct List
| Product Name | Synonyms | CAS No. | Grate/Content | Operate |
|---|---|---|---|---|
4H-Dibenzo[de,g]quinoline-10,11-diol,5,6,6a,7-tetrahydro-6-methyl-, hydrochloride, hydrate (2:2:1), (6aR)- |
4H-Dibenzo[de,g]quinoline-10,11-diol,5,6,6a,7-tetrahydro-6-methyl-,hydrochloride,hydrate (2:2:1),(6aR)-;4H-Dibenzo[de,g]quinoline-10,11-diol,5,6,6a,7-tetrahydro-6-methyl-,hydrochloride,hydrate (2:1),(R)-;4H-Dibenzo[de,g]quinoline-10,11-diol,5,6,6a,7-tetrahydro-6-methyl-,hydrochloride,hydrate (2:1),(6aR)-;Apomorphine hydrochloride hemihydrate;(R)-(-)-Apomorphine hydrochloride hemihydrate |
41372-20-7 | Inquiry | |
Benzenaminium,N-ethyl-3-hydroxy-N,N-dimethyl-, chloride (1:1) |
Benzenaminium,N-ethyl-3-hydroxy-N,N-dimethyl-,chloride (1:1);Ammonium,ethyl(m-hydroxyphenyl)dimethyl-,chloride;Benzenaminium,N-ethyl-3-hydroxy-N,N-dimethyl-,chloride;Ethyl(m-hydroxyphenyl)dimethylammonium chloride;Dimethylethyl(3-hydroxyphenyl)ammonium chloride;Edrophonium chloride;Tensilon chloride;Tensilon;Ethyl(3-hydroxyphenyl)dimethylammonium chloride;Antirex;Reversol;Enlon;Edrophone chloride |
116-38-1 | Inquiry | |
Bimatoprost |
5-Heptenamide,7-[(1R,2R,3R,5S)-3,5-dihydroxy-2-[(1E,3S)-3-hydroxy-5-phenyl-1-penten-1-yl]cyclopentyl]-N-ethyl-,(5Z)-;5-Heptenamide,7-[3,5-dihydroxy-2-(3-hydroxy-5-phenyl-1-pentenyl)cyclopentyl]-N-ethyl-,[1R-[1α(Z),2β(1E,3S*),3α,5α]]-;5-Heptenamide,7-[(1R,2R,3R,5S)-3,5-dihydroxy-2-[(1E,3S)-3-hydroxy-5-phenyl-1-pentenyl]cyclopentyl]-N-ethyl-,(5Z)-;(5Z)-7-[(1R,2R,3R,5S)-3,5-Dihydroxy-2-[(1E,3S)-3-hydroxy-5-phenyl-1-penten-1-yl]cyclopentyl]-N-ethyl-5-heptenamide;Bimatoprost;AGN 192024;Lumigan;Prostamide;Latisse;17-Phenyltrinor-PGF2α ethylamide;267244-98-4 |
155206-00-1 | Inquiry | |
Carboplatin |
PARAPLATIN;1,1-cyclobutanedicarboxylatediammineplatinum(ii);1-cyclobutanedicarboxylato(2-)-o,o’)-diammine((sp-4-2)-platinu;1-cyclobutanedicarboxylato)diammine-(cis-platinum(ii;DIAMMINE(1,1-CYCLOBUTANEDICARBOXYLATO)PLATINUM(II);CARBOPLATIN;CARBOPLATINUM;CIS-DIAMINE(1,1-CYCLOBUTANEDICARBOXYLATO)PLATINUM |
41575-94-4 | Inquiry | |
Carmustin |
Urea,N,N′-bis(2-chloroethyl)-N-nitroso-;Urea,1,3-bis(2-chloroethyl)-1-nitroso-;N,N′-Bis(2-chloroethyl)-N-nitrosourea;BCNU;1,3-Bis(2-chlorethyl)-1-nitrosourea;Carmustine;1,3-Bis(β-chloroethyl)-1-nitrosourea;NSC 409962;Carmustin;1,3-Bis(2-chloroethyl)-1-nitrosourea;BiCNU;Gliadel;Becenun;SK 27702;SRI 1720;Nitrumon;FDA 0345;Carmubris;DTI 015;Gliadel Wafer;1,3-Bis(2-chloroethyl)nitrosourea;Becenum;1159711-15-5;1191292-23-5 |
154-93-8 | Inquiry | |
Cisplatin |
Platinum,diamminedichloro-,(SP-4-2)-;Platinum,diamminedichloro-,cis-;(SP-4-2)-Diamminedichloroplatinum;cis-Diamminedichloroplatinum;cis-Dichlorodiamineplatinum(II);cis-Platinum(II) diaminodichloride;cis-Platinum(II) diamminedichloride;cis-Dichlorodiammineplatinum;cis-Platinous diaminodichloride;cis-Platinum diaminodichloride;cis-Platinumdiammine dichloride;cis-Platinumdiamine dichloride;cis-Diaminodichloroplatinum(II);NSC 119875;Cisplatin;cis-Platinum II;Platinol;Neoplatin;cis-Platine;Biocisplatinum;cis-DDP;cis-Diamminedichloroplatinum(II);Platidiam;cis-Platinum;Cisplatinum;CPDD;cis-Platin;cis-Dichlorodiammineplatinum(II);TR 170;CDDP;DDP;CPPD;cis-Diaminedichloroplatinum(II);Cisplatyl;Briplatin;DDP (antitumor agent);Abiplatin;SPI 077;CACP;Lederplatin;Platosin;Platamine;Platiblastin;Platistin;Platinoxan;CPDC;Cismaplat;Citoplatino;Rand;Platinex;Platinol AQ;SPI 077 (complex);SPI 077B103;Cisplatino;Lipoplatin;Randa;Fauldiscipla;IA-call;CP Ethypharm;LiPlaCis;Cisplatine Mylan;Kemoplat;Citoplax;Maruko;cis-Diaminedichloridoplatinum(II);cis-Diammineplatinum(II);96081-74-2;936542-99-3 |
15663-27-1 | Inquiry | |
Galanthamine hydrobromide |
6H-Benzofuro[3a,3,2-ef][2]benzazepin-6-ol,4a,5,9,10,11,12-hexahydro-3-methoxy-11-methyl-,hydrobromide (1:1),(4aS,6R,8aS)-;Galanthamine,hydrobromide;6H-Benzofuro[3a,3,2-ef][2]benzazepin-6-ol,4a,5,9,10,11,12-hexahydro-3-methoxy-11-methyl-,hydrobromide,(4aS,6R,8aS)-;Galantamine hydrobromide;Nivalin;Nivaline;Galanthamine hydrogen bromide;Nivaline (pharmaceutical);(-)-Galanthamine hydrobromide;Reminyl;Jilkon hydrobromide;Lycoremine hydrobromide;(-)-Galantamine hydrobromide;Razadyne;Tamilin |
1953-04-4 | Inquiry | |
Gold, [1-(thio-kS)-b-D-glucopyranose2,3,4,6-tetraacetato](triethylphosphine)- |
Gold,[1-(thio-κS)-β-D-glucopyranose 2,3,4,6-tetraacetato](triethylphosphine)-;Gold,(1-thio-β-D-glucopyranose 2,3,4,6-tetraacetato-S)(triethylphosphine)-;Gold,(1-thio-β-D-glucopyranosato)(triethylphosphine)-,2,3,4,6-tetraacetate;β-D-Glucopyranose,1-thio-,2,3,4,6-tetraacetate,gold complex;[1-(Thio-κS)-β-D-glucopyranose 2,3,4,6-tetraacetato](triethylphosphine)gold;[(Tetra-O-acetyl-β-D-glucopyranosyl)thio](triethylphosphine)gold;SKF 39162D;Auranofin;Ridaura;SKF 39162;Crisofin;Crisinor;Aktil;Ridauran;NSC 321521;Gold Salt |
34031-32-8 | Inquiry | |
Oxaliplatin |
Platinum,[(1R,2R)-1,2-cyclohexanediamine-κN1,κN2][ethanedioato(2-)-κO1,κO2]-,(SP-4-2)-;Platinum,(1,2-cyclohexanediamine-N,N′)[ethanedioato(2-)-O,O′]-,[SP-4-2-(1R-trans)]-;Platinum,[(1R,2R)-1,2-cyclohexanediamine-κN,κN′][ethanedioato(2-)-κO1,κO2]-,(SP-4-2)-;1,2-Cyclohexanediamine,platinum complex,(1R-trans)-;(SP-4-2)-[(1R,2R)-1,2-Cyclohexanediamine-κN1,κN2][ethanedioato(2-)-κO1,κO2]platinum;NSC 266046;Oxalatoplatinum;Oxalatoplatin;l-OHP;Oxaliplatin;RP 54780;Platinum,(1,2-cyclohexanediamine-κN,κN′)[ethanedioato(2-)-κO1,κO2]-,[SP-4-2-(1R-trans)]-;Oxalato[trans-(-)-1,2-cyclohexanediamine]platinum(II);Oxalato(trans-l-1,2-cyclohexanediamine)platinum(II);Eloxatin;Dacplat;trans-L-Diaminocyclohexane oxalatoplatinum;Elplat;Lipoxal |
61825-94-3 | Inquiry | |
Platinum, bis(acetato-kO)amminedichloro(cyclohexanamine)-,(OC-6-43)- (9CI) |
Platinum,bis(acetato-κO)amminedichloro(cyclohexanamine)-,(OC-6-43)-;Platinum,bis(acetato-O)amminedichloro(cyclohexanamine)-,(OC-6-43)-;Cyclohexanamine,platinum complex;JM 216;Satraplatin;BMY 45594;POplat;BMS 182751;367265-85-8 |
129580-63-8 | Inquiry | |
Platinum,amminedichloro(2-methylpyridine)-, (SP-4-3)- |
Platinum,amminedichloro(2-methylpyridine)-,(SP-4-3)-;(SP-4-3)-Amminedichloro(2-methylpyridine)platinum;AMD 473;ZD 0473;Picoplatin;NX 473 |
181630-15-9 | Inquiry | |
Prosta-5,13-dien-1-oicacid, 11,15-dihydroxy-9-oxo-, (5Z,11a,13E,15S)- |
Prosta-5,13-dien-1-oic acid,11,15-dihydroxy-9-oxo-,(5Z,11α,13E,15S)-;5-Heptenoic acid,7-[3-hydroxy-2-(3-hydroxy-1-octenyl)-5-oxocyclopentyl]-;5-Heptenoic acid,7-[3α-hydroxy-2-(3-hydroxy-1-octenyl)-5-oxocyclopentyl]-;(5Z,11α,13E,15S)-11,15-Dihydroxy-9-oxoprosta-5,13-dien-1-oic acid;PGE2;Prostaglandin E2;U 12062;11α,15α-Dihydroxy-9-oxo-5-cis,13-trans-prostadienoic acid;(15S)-Prostaglandin E2;(-)-Prostaglandin E2;11α,15α-Dihydroxy-9-ketoprosta-5,13-dienoic acid;Dinoprostone;Prostin E2;Prepidil;l-Prostaglandin E2;l-PGE2;Minprostin E2;Prostenon;Prostenone;Cervidil;Prostin;Prostin (prostaglandin);Glandin;Prostarmon E;Cerviprost;Propess;Minprositin E2;Enzaprost E;NSC 165560;NSC 196514;Primiprost;Cerviprime;11,15-Dihydroxy-9-oxoprosta-5,13-dien-1-oic acid (5Z,11α,13E,15S);5: PN: US20150065431 SEQID: 5 claimed sequence;7-[3-hydroxy-2-(3-hydroxy-1-octenyl)-5-oxo-cyclopentyl]-5-heptenoic acid |
363-24-6 | Inquiry | |
Prostaglandin E1 |
Prost-13-en-1-oic acid,11,15-dihydroxy-9-oxo-,(11α,13E,15S)-;Cyclopentaneheptanoic acid,3-hydroxy-2-(3-hydroxy-1-octenyl)-5-oxo-,(-)-;Cyclopentaneheptanoic acid,3α-hydroxy-2-(3-hydroxy-1-octenyl)-5-oxo-;(11α,13E,15S)-11,15-Dihydroxy-9-oxoprost-13-en-1-oic acid;PGE1;Prostaglandin E1;11α,15(S)-Dihydroxy-9-oxo-13-trans-prostenoic acid;(-)-Prostaglandin E1;l-Prostaglandin E1;11α,15α-Dihydroxy-9-oxo-13-trans-prostenoic acid;Alprostadil;U 10136;Prostandin;l-PGE1;Prostandin 500;Caverject;Alprox TD;Palux;ONO 1608;Lipoprost;Topiglan;SEPA-PGE1;SEPA-alprostadil;SEPA-prostaglandin E1;Minprog;Prostivas;Prostin VR Pediatric;Liple;NSC 165559;Caveject;Vasaprostan;Liprostin;Eglandin;Lipo PGE1;Alprostan;50-83-9;22299-37-2;50865-30-0 |
745-65-3 | Inquiry |